• Patients
  • Careers
  • Contact
Frequency Therapeutics
  • About

    About

    We are a clinical-stage biotechnology company focused on restoring function by developing therapeutics that activate a person’s innate regenerative potential.

    • About Us
    • Leadership
    • Board of Directors
    • PCA Regenerative Medicine Advisory Board
    • Hearing Clinical Advisory Board
    • Remyelination Advisory Board
  • Our Science

    Our Science

    Frequency is leading a new category in regenerative medicine designed to activate a person’s innate regenerative potential, within the body, to repair tissue and restore function.

    • PCA Approach
    • Therapeutic Discovery Process
    • Publications
  • Pipeline & Programs

    Pipeline & Programs

    Developing small-molecule treatments to reverse the debilitating impact of degenerative diseases

    • Pipeline
    • Hearing Program
    • Multiple Sclerosis Program
    • Strategic Partnerships
  • Hearing Loss

    Hearing Loss

    Hearing loss caused by damage to the sensory cells of the ear impacts hundreds of millions of people globally. Currently there are no FDA-approved treatments to address the underlying condition.

    • About Hearing Loss
    • How We Hear
    • Sensorineural Hearing Loss
    • Sound Clarity and Speech Perception
    • Hearing Loss: A Growing Public Health Problem
  • Investors & Media

    Investors & Media

    • Overview
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQ
    • Investor & Media Contacts
  • About
    • About Us
    • Leadership
    • Board of Directors
    • PCA Regenerative Medicine Advisory Board
    • Hearing Clinical Advisory Board
    • Remyelination Advisory Board
  • Our Science
    • PCA Approach
    • Therapeutic Discovery Process
    • Publications
  • Pipeline & Programs
    • Pipeline
    • Hearing Program
    • Multiple Sclerosis Program
    • Strategic Partnerships
  • Hearing Loss
    • About Hearing Loss
    • How We Hear
    • Sensorineural Hearing Loss
    • Sound Clarity and Speech Perception
    • Hearing Loss: A Growing Public Health Problem
  • Investors & Media
    • Overview
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQ
    • Investor & Media Contacts
  • Patients
  • Careers
  • Contact Us

Clinical Advisory Board

Read Bio

Daniel J. Lee, MD

Massachusetts Eye and Ear; Harvard Medical School

Read Bio

David R. Friedland, MD, PhD

Medical College of Wisconsin

Read Bio

René H. Gifford, PhD, CCC-A

Vanderbilt University

Read Bio

Steven D. Rauch, MD

Massachusetts Eye and Ear/Harvard Medical School

Read Bio

Christina Runge, PhD, CCC-A

Medical College of Wisconsin

Read Bio

Joni K. Doherty, MD, PhD

Keck School of Medicine of the University of Southern California

Read Bio

Ruth Litovsky, PhD

University of Wisconsin – Madison

Read Bio

Julie Arenberg, MS, PhD

Massachusetts Eye and Ear/Harvard Medical School

Interested in joining our team? Explore careers

© 2023 Frequency Therapeutics
  • Open Positions
  • Contact
  • Privacy Policy
  • Terms & Conditions